Adrenocortical carcinoma

Active Research Protocols

  1. 00-CH-0160 – Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue
  2. 10-C-0203 – Phase II Study of Axitinib (AG-013736) with Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer
  3. 11-C-0038 – A Phase 2 Study of Vorinostat in Subjects with Locally Advanced, Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) (IND 71976)
  4. 11-C-0149 – Evaluation of Diagnostic and Prognostic Molecular Markers in Adrenal Neoplasm
  5. 13-C-0046 – A Phase I/II Trial of IL-13-PE in Patients with Treatment Refractory Malignancies with a Focus on Metastatic and Locally Advanced Adrenocortical Carcinoma
  6. 13-C-0083 – Efficacy of Adjuvant Mitotane Treatment in Prolonging Recurrence-Free Survival in Patients with Adrenocortical Carcinoma at Low-intermediate Risk of Recurrence
  7. 13-C-0114 – Phase II Trial of Surgical Resection and Heated Intraperitoneal Peritoneal Chemotherapy (HIPEC) for Adrenocortical Carcinoma
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014